Industry Research Reports

An adjuvant is a pharmacological or immunological agent that modifies the effect of other agents.

An adjuvant is a pharmacological or immunological agent that modifies the effect of other agents.

The global Immune Adjuvant market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Freund's adjuvants are immunoadjuvants, a class of agents that are not antigenic in themselves but which, when injected into the animal together with the antigen, enhance the immune effect by delaying the elimination of the antigen. The most commonly used immunoadjuvants are Freund's incomplete adjuvant and Freund's complete adjuvant.

Freund's adjuvants are immunoadjuvants, a class of agents that are not antigenic in themselves but which, when injected into the animal together with the antigen, enhance the immune effect by delaying the elimination of the antigen. The most commonly used immunoadjuvants are Freund's incomplete adjuvant and Freund's complete adjuvant.

The global market for Immune Adjuvant was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Freund's adjuvants are immunoadjuvants, a class of agents that are not antigenic in themselves but which, when injected into the animal together with the antigen, enhance the immune effect by delaying the elimination of the antigen. The most commonly used immunoadjuvants are Freund's incomplete adjuvant and Freund's complete adjuvant.

The global Immune Adjuvant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal.

Adjuvant peptides are synthetic immunoreactive peptides that induce immune responses to enhance the immune system's recognition and attack of tumors. The adjuvant peptide is connected to the short amino acid chain of N-acetylteiic acid and L-Ala-D-isoGln. It upregulates Runx2 gene expression through the MAPK pathway, directly promotes osteoblast differentiation, inhibits osteoclast formation, and thereby promotes bone formation. Adjuvant peptides can also be used to prevent osteoporosis.